Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.76 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.65 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.63 |
| ▸ | HRH1 | P35367 | 2/20 | 0.63 |
| ▸ | HTR2B | P41595 | 2/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.63 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.63 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.63 |
| ▸ | MLNR | O43193 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29409726 | 0.99 | ALDH1A1 (0.84) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL7649694 | 0.97 | ALDH1A1 (0.82) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL1697179 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL10098821 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL9889332 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL5391765 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL5391762 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL5395653 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL418425 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 | |
| SCHEMBL5395648 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309732-B2 | Process for preparing quaternary salts of piperidyl esters of mandelic acid | SALTIGO GMBH (US) | 2012-11-13 | — | — | US | claimed |
| US-20090270629-A1 | PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID | SALTIGO GMBH (DE) | 2009-10-29 | — | — | US | claimed |
| US-8633225-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2014-01-21 | — | — | US | disclosed |
| US-8633225-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2014-01-21 | — | — | US | disclosed |
| EP-2032118-B1 | COSMETIC COMPOSITIONS CONTAINING PIPERIDINIUM COMPOUNDS | BEIERSDORF AG (DE) | 2012-12-19 | — | — | EP | disclosed |
| US-8309732-B2 | Process for preparing quaternary salts of piperidyl esters of mandelic acid | SALTIGO GMBH (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309732-B2 | Process for preparing quaternary salts of piperidyl esters of mandelic acid | SALTIGO GMBH (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309732-B2 | Process for preparing quaternary salts of piperidyl esters of mandelic acid | SALTIGO GMBH (US) | 2012-11-13 | — | — | US | disclosed |
| US-20110044923-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | BEIERSDORF AG (DE) | 2011-02-24 | — | — | US | disclosed |
| US-20110044923-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | BEIERSDORF AG (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7851633-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2010-12-14 | — | — | US | disclosed |
| US-7851633-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2010-12-14 | — | — | US | disclosed |
| US-20090270629-A1 | PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID | SALTIGO GMBH (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090270629-A1 | PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID | SALTIGO GMBH (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090270629-A1 | PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID | SALTIGO GMBH (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20070292375-A1 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2007-12-20 | — | — | US | disclosed |
| US-20070292375-A1 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2007-12-20 | — | — | US | disclosed |
| WO-2007141289-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | BEIERSDORF AG (DE) | 2007-12-13 | — | — | WO | disclosed |
| US-6482837-B1 | Antimuscarinic compounds and methods for treatment of bladder diseases | UNIVERSITY OF ROCHESTER | 2002-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292375-A1 | Piperidinium compounds and cosmetic compositions containing them | CUTA, DPM1, TRPA1 | ALDH1A1 155/4885CYP1A2 1589/4885CYP3A4 3456/4885 |
| US-20090270629-A1 | PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID | MYD88, ETF1, C5 | ALDH1A1 293/4885CYP1A2 169/4885CYP3A4 563/4885 |
| US-20110044923-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | CUTA, DPM1, TRPA1 | ALDH1A1 155/4885CYP1A2 1589/4885CYP3A4 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.